Sign inGet started

Paramore Miriam J

Insider CIK 1713156 · OPRX RESIDENT

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OPRX OptimizeRx Corp M Exercise deriv2021-12-022021-12-033,558$7.51 $26.7K90,760SEC↗
OPRX OptimizeRx Corp M Exercise2021-12-022021-12-033,558$7.51 $26.7K74,607SEC↗
OPRX OptimizeRx Corp S Sale2021-12-022021-12-033,558$61.48 $218.7K71,049SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-11-022021-11-0315,000— $094,318SEC↗
OPRX OptimizeRx Corp S Sale2021-11-022021-11-0315,000$95.45 $1.43M74,607SEC↗
OPRX OptimizeRx Corp M Exercise2021-11-022021-11-0315,000$7.51 $112.7K89,607SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-10-042021-10-0515,000— $0109,318SEC↗
OPRX OptimizeRx Corp M Exercise2021-10-042021-10-0515,000$7.51 $112.7K89,607SEC↗
OPRX OptimizeRx Corp S Sale2021-10-042021-10-0515,000$84.67 $1.27M74,607SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-09-022021-09-0315,000— $0124,318SEC↗
OPRX OptimizeRx Corp M Exercise2021-09-022021-09-0315,000$7.51 $112.7K89,607SEC↗
OPRX OptimizeRx Corp S Sale2021-09-022021-09-0315,000$68.39 $1.03M74,607SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-08-022021-08-0315,000— $0139,318SEC↗
OPRX OptimizeRx Corp S Sale2021-08-022021-08-0315,000$55.76 $836.4K74,607SEC↗
OPRX OptimizeRx Corp M Exercise2021-08-022021-08-0315,000$7.51 $112.7K89,607SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-07-152021-07-1971,667— $0154,318SEC↗
OPRX OptimizeRx Corp M Exercise2021-07-152021-07-1967,195$3.15 $211.7K74,607SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-07-022021-07-0215,000— $0225,985SEC↗
OPRX OptimizeRx Corp S Sale2021-07-022021-07-0215,000$57.81 $867.1K7,412SEC↗
OPRX OptimizeRx Corp M Exercise2021-07-022021-07-0215,000$3.15 $47.3K22,412SEC↗
OPRX OptimizeRx Corp M Exercise deriv2021-06-042021-06-0813,333— $0240,985SEC↗
OPRX OptimizeRx Corp M Exercise2021-06-042021-06-0813,333$3.15 $42.0K20,745SEC↗
OPRX OptimizeRx Corp S Sale2021-06-042021-06-0813,333$50.85 $678.0K7,412SEC↗
OPRX OptimizeRx Corp S Sale2021-06-042021-06-081,667$51.30 $85.5K7,412SEC↗
OPRX OptimizeRx Corp S Sale2021-05-172021-05-1915,000$42.95 $644.3K9,079SEC↗
OPRX OptimizeRx Corp A Award deriv2021-01-072021-01-1124,093— $0254,318SEC↗
OPRX OptimizeRx Corp A Award deriv2020-03-112020-03-1363,558— $0230,225SEC↗
OPRX OptimizeRx Corp C Conversion deriv2019-03-272019-03-2916,667— $010,000SEC↗
OPRX OptimizeRx Corp A Award2019-03-272019-03-2916,667— $024,079SEC↗
OPRX OptimizeRx Corp A Award deriv2019-02-252019-02-2610,000— $026,667SEC↗
OPRX OptimizeRx Corp P Buy2018-12-192018-12-201,015$9.85 $10.0K7,412SEC↗
OPRX OptimizeRx Corp P Buy2018-06-222018-06-26100$10.50 $1.1K6,397SEC↗
OPRX OptimizeRx Corp P Buy2018-06-152018-06-183,400$8.05 $27.4K6,297SEC↗
OPRX OptimizeRx Corp P Buy2018-06-152018-06-181,600$8.11 $13.0K7,897SEC↗
OPRX OptimizeRx Corp A Award deriv2018-02-012018-02-0250,000— $0550,000SEC↗
OPRX OptimizeRx Corp P Buy2017-09-252017-10-068,690$1.21 $10.5K8,690SEC↗